INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE

The present invention discloses a liquid pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) active levalbuterol or a salt thereof, such as lev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HUANG, Hua, HUANG, Cai Gu
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HUANG, Hua
HUANG, Cai Gu
description The present invention discloses a liquid pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) active levalbuterol or a salt thereof, such as levalbuterol tartrate; (b) a pharmacologically acceptable preservative; (c) a pharmacologically acceptable stabilizer, (d) a solvent, and optionally (e) other pharmacologically acceptable additives. La présente invention concerne une préparation pharmaceutique liquide et un procédé d'administration d'une préparation pharmaceutique par nébulisation de la préparation pharmaceutique dans un inhalateur. La préparation pharmaceutique sans propulseur comprend : (a) du lévalbutérol actif ou un sel de celui-ci, tel que le tartrate de lévalbutérol ; (b) un conservateur pharmaceutiquement acceptable ; (c) un stabilisant pharmacologiquement acceptable, (d) un solvant, et éventuellement (e) d'autres additifs pharmacologiquement acceptables.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021188809A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021188809A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021188809A13</originalsourceid><addsrcrecordid>eNrjZHDx9PNw9HF08nFVcPMP8g31cQzx9PdT8HdTcFQI9vcJBfOc_f1CHD39PP3cFXxcwxx9nEJDXIP8fRRCHINCghxDXHkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkaGhhYWFgaWjoTFxqgApUi0O</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE</title><source>esp@cenet</source><creator>HUANG, Hua ; HUANG, Cai Gu</creator><creatorcontrib>HUANG, Hua ; HUANG, Cai Gu</creatorcontrib><description>The present invention discloses a liquid pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) active levalbuterol or a salt thereof, such as levalbuterol tartrate; (b) a pharmacologically acceptable preservative; (c) a pharmacologically acceptable stabilizer, (d) a solvent, and optionally (e) other pharmacologically acceptable additives. La présente invention concerne une préparation pharmaceutique liquide et un procédé d'administration d'une préparation pharmaceutique par nébulisation de la préparation pharmaceutique dans un inhalateur. La préparation pharmaceutique sans propulseur comprend : (a) du lévalbutérol actif ou un sel de celui-ci, tel que le tartrate de lévalbutérol ; (b) un conservateur pharmaceutiquement acceptable ; (c) un stabilisant pharmacologiquement acceptable, (d) un solvant, et éventuellement (e) d'autres additifs pharmacologiquement acceptables.</description><language>eng ; fre</language><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210923&amp;DB=EPODOC&amp;CC=WO&amp;NR=2021188809A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210923&amp;DB=EPODOC&amp;CC=WO&amp;NR=2021188809A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HUANG, Hua</creatorcontrib><creatorcontrib>HUANG, Cai Gu</creatorcontrib><title>INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE</title><description>The present invention discloses a liquid pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) active levalbuterol or a salt thereof, such as levalbuterol tartrate; (b) a pharmacologically acceptable preservative; (c) a pharmacologically acceptable stabilizer, (d) a solvent, and optionally (e) other pharmacologically acceptable additives. La présente invention concerne une préparation pharmaceutique liquide et un procédé d'administration d'une préparation pharmaceutique par nébulisation de la préparation pharmaceutique dans un inhalateur. La préparation pharmaceutique sans propulseur comprend : (a) du lévalbutérol actif ou un sel de celui-ci, tel que le tartrate de lévalbutérol ; (b) un conservateur pharmaceutiquement acceptable ; (c) un stabilisant pharmacologiquement acceptable, (d) un solvant, et éventuellement (e) d'autres additifs pharmacologiquement acceptables.</description><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</subject><subject>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</subject><subject>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDx9PNw9HF08nFVcPMP8g31cQzx9PdT8HdTcFQI9vcJBfOc_f1CHD39PP3cFXxcwxx9nEJDXIP8fRRCHINCghxDXHkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkaGhhYWFgaWjoTFxqgApUi0O</recordid><startdate>20210923</startdate><enddate>20210923</enddate><creator>HUANG, Hua</creator><creator>HUANG, Cai Gu</creator><scope>EVB</scope></search><sort><creationdate>20210923</creationdate><title>INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE</title><author>HUANG, Hua ; HUANG, Cai Gu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021188809A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</topic><topic>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</topic><topic>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HUANG, Hua</creatorcontrib><creatorcontrib>HUANG, Cai Gu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HUANG, Hua</au><au>HUANG, Cai Gu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE</title><date>2021-09-23</date><risdate>2021</risdate><abstract>The present invention discloses a liquid pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) active levalbuterol or a salt thereof, such as levalbuterol tartrate; (b) a pharmacologically acceptable preservative; (c) a pharmacologically acceptable stabilizer, (d) a solvent, and optionally (e) other pharmacologically acceptable additives. La présente invention concerne une préparation pharmaceutique liquide et un procédé d'administration d'une préparation pharmaceutique par nébulisation de la préparation pharmaceutique dans un inhalateur. La préparation pharmaceutique sans propulseur comprend : (a) du lévalbutérol actif ou un sel de celui-ci, tel que le tartrate de lévalbutérol ; (b) un conservateur pharmaceutiquement acceptable ; (c) un stabilisant pharmacologiquement acceptable, (d) un solvant, et éventuellement (e) d'autres additifs pharmacologiquement acceptables.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2021188809A1
source esp@cenet
subjects DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A21%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HUANG,%20Hua&rft.date=2021-09-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021188809A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true